The field of diabetes treatment has seen a surge in innovation with the emergence of novel GLP-1 receptor agonists. Among these, retatrutide and trizepatide are rapidly emerging as potential game-changers. These of https://matteojyvi191766.blog2freedom.com/39103365/new-glp-1-receptor-agonists-retatrutide-and-trizepatide